The Management of Non-neurogenic Male LUTS (Lower Urinary Tract Symptoms)
A special issue of Uro (ISSN 2673-4397).
Deadline for manuscript submissions: closed (15 April 2022) | Viewed by 22549
Interests: prostate; benign prostatic hyperplasia; male lower urinary tract symptoms; prostate cancer; kidney cancer; robotic surgery
The latest report on “World Population Ageing 2019” by United Nations reported that population aging is a global phenomenon, with 703 million persons aged 65 years or over around the world in 2019. The number of older persons is projected to double to 1.5 billion in 2050. It is well known that aging is one of the most important risk factors for the development of benign prostatic hyperplasia (BPH) and benign prostatic obstruction (BPO), which can lead to lower urinary tract symptoms (LUTS) and worsen quality of life: about a quarter of middle-aged and elderly men reported clinically relevant LUTS. A number of medical and surgical treatments for LUTS/BPH exist, from phytotherapy to combination therapies, from mini-invasive robot-assisted surgery to open prostatectomy. Recent insights into the pathophysiology and management of male non-neurogenic LUTS have led to the introduction of new concepts such as the patient’s perspective, patient’s quality of life, and focus on treatment-related adverse effects. In this sense, the management of male non-neurogenic LUTS is an intriguing and challenging field in everyday clinical practice that requires continuous updates. In this Special Issue about the management of male non-neurogenic LUTS, we aim to discuss the newest findings concerning the medical and surgical treatment of LUTS, also taking into account the patient’s perspective and quality of life.
Key areas of this Special Issue include but are not limited to prostate, benign prostatic hyperplasia, benign prostatic obstruction, male lower urinary tract symptoms, mini-invasive surgery, phytotherapy, and medical treatment.
We hope to provide readers with an interesting tool for use in everyday clinical practice and invite many colleagues to focus part of their clinical research in the male non-neurogenic LUTS management field.
Prof. Dr. Mauro Gacci
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Uro is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- benign prostatic hyperplasia
- benign prostatic obstruction
- lower urinary tract symptoms
- mini-invasive surgery
- alpha blockers
- laser surgery
- 5-alpha-reductase inhibitors
- quality of life